Resistance to antiparasitic drugs poses significant challenges, leading to increased dosages and prolonged treatment durations, which can exacerbate toxic effects. Ongoing research is focused on developing new drugs with better safety profiles and exploring combination therapies to minimize resistance and toxicity.
